Xiang Jia-Mei, Zhong Guo-Yue, Jiang Wei, Ren Gang
Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine, Jiangxi University of Traditional Chinese Medicine Nanchang 330004, China.
Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(2):488-493. doi: 10.19540/j.cnki.cjcmm.20200902.601.
On the basis of literatures and standards relating to Tibetan medicine, the varieties, origin, standards and efficacy of Saxifragaceae plant used in Tibetan medicine were summarized. According to the findings, 75 species(including varieties) in 8 genera of Saxifragaceae plants, involving 21 varieties, are used in Tibetan medicine. Among them, 9 commonly used varieties, namely Songdi, Sedi, Yajima, Aoledansaierbao, Jiansidawu, Saiguo, Katuer, Sangdi, Maoqinghong, are recorded in Chinese Pharmacopoeia, Ministry Standards for Tibetan Medicine, Tibetan Medicine Standards and other local standards, accounting for 42.9% of the total number of varieties. Tibetan names, Tibetan translation of Chinese names, as well as original plant of Tibetan medicine varieties are quite different in relevant Tibetan medicine standards and literatures, which resulted in common phenomena of synonym and homonym. The standards of most varieties only involve characters, and microscopic, physical and chemical identification, with low quality standards. Based on the results of the analysis, this paper suggests strengthening surveys on herbal textual research, resources and current utilization of Saxifragaceae plants used in Tibetan medicine, summarizing the varieties, establishing improved quality standards, and perfor-ming a comparative study on therapeutic material basis and biological activity of different original plants, in order to promote rational use of these medicinal plant resources, and ensuring the accuracy, safety, and effectiveness of clinical medication.
基于藏医药相关文献和标准,对藏药中虎耳草科植物的品种、来源、标准及功效进行了总结。结果表明,藏药中使用的虎耳草科植物有8属75种(包括变种),涉及21个品种。其中,9个常用品种,即松蒂、色地、亚吉玛、奥勒丹赛尔保、坚西达乌、赛果、卡特尔、桑蒂、毛青红,被《中国药典》《藏药部颁标准》《藏药标准》等地方标准收录,占品种总数的42.9%。在相关藏药标准和文献中,藏药品种的藏文名称、汉文名称的藏文翻译以及原植物存在较大差异,导致同物异名和同名异物现象普遍。多数品种标准仅涉及性状、显微、理化鉴别,质量标准较低。基于分析结果,本文建议加强对藏药中虎耳草科植物本草考证、资源及当前利用情况的调研,总结品种,制定完善的质量标准,对不同原植物的药效物质基础和生物活性进行对比研究,以促进这些药用植物资源的合理利用,确保临床用药的准确性、安全性和有效性。